ClinicalTrials.gg
CompletedNCT07938502Updated Nov 16, 2026

Sexual Dysfunction in Young Adult Men

An observational study in Erectile Dysfunction and Premature Ejaculation, sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Ondokuz Mayıs University · Observational

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
253
Ages
18 Years to 40 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 32 studies in Erectile Dysfunction with a site in Turkey — 6 open to participants now, 8 under way, 2 of them phase 3. Erectile Dysfunction · Turkey.

Enrollment
4th of 15
253 · median 130
Started
2026
with 4 others
Observational
15 of 32
1 open now
Registered
32nd of 32
by date

Among the 32 studies in Erectile Dysfunction with a site in Turkey, this one is the 4th largest by enrollment of the 15 observational ones that give a count, is one of 5 that started in 2026, is one of 15 observational ones, and was the 32nd registered.

Erectile Dysfunction

702 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.

Browse Erectile Dysfunction studies →

Open to participants now

6 of the 32 studies in Erectile Dysfunction with a site in Turkey are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 78 Erectile Dysfunction studies recruiting now, 31 (40%) set no upper age limit and 34 (44%) stop at 75 or younger; 2 take children under 18; 7 take healthy volunteers.

This study: 18 Years to 40 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Erectile Dysfunction with a site in Turkey, or all of them as a file.
02

Study summary

This single-center cross-sectional study aims to determine the prevalence of erectile dysfunction and premature ejaculation in sexually active men aged 18 to 40 years and to evaluate their association with depressive and anxiety symptoms, lifestyle factors, and sociodemographic characteristics. Participants attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups completed a structured questionnaire, the International Index of Erectile Function-15 (IIEF-15), the Premature Ejaculation Diagnostic Tool (PEDT), the Beck Depression Inventory, and the Generalized Anxiety Disorder-7 (GAD-7) scale.

03

Conditions studied

  • Erectile Dysfunction
  • Premature Ejaculation

Keywords

  • young adult men
  • prevalence
  • anxiety
  • depression
  • PEDT
  • IIEF-15
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Sexually active men aged 18 to 40 years attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups.

Eligibility criteria

Inclusion Criteria:

  • Inclusion Criteria:
  • Male, aged 18 to 40 years
  • Sexual activity within the previous six months
  • Attending Ondokuz Mayis University Hospital outpatient clinics for a routine health check-up
  • Ability to read and write Turkish and to complete the questionnaire
  • Written

Exclusion Criteria:

  • History of spinal cord injury
  • Active cancer or ongoing chemotherapy/radiotherapy
  • Cognitive, psychiatric, or communication impairment preventing reliable completion of the questionnaire
  • Incomplete or inconsistent questionnaire data precluding analysis

Exclusion Criteria:

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
253 participants (actual)
Patient registry
No

Groups and cohorts

  • Sexually active men aged 18-40 years

    Men attending outpatient clinics for routine health check-ups who completed IIEF-15, PEDT, Beck Depression Inventory and GAD-7.

06

What researchers measure

Primary outcomes

  1. Prevalence of erectile dysfunction

    Proportion of participants with an IIEF-15 erectile function domain score of 25 or lower.

    Time frame: At enrollment (single cross-sectional assessment)

  2. Prevalence of premature ejaculation

    Proportion of participants with a PEDT total score of 11 or higher.

    Time frame: At enrollment (single cross-sectional assessment)

Secondary outcomes

  1. Association of anxiety symptoms with sexual dysfunction

    Association of GAD-7 score (10 or higher defined as anxiety) with erectile dysfunction and premature ejaculation.

    Time frame: At enrollment

  2. Association of depressive symptoms with sexual dysfunction

    Association of Beck Depression Inventory score (17 or higher defined as depression) with erectile dysfunction and premature ejaculation.

    Time frame: At enrollment

  3. Association of lifestyle and sociodemographic factors with sexual dysfunction

    Association of BMI, waist circumference, smoking, alcohol use, physical activity, working pattern, weekly working hours, education, income and marital status with erectile dysfunction and premature ejaculation.

    Time frame: At enrollment

07

Study locations

1 site
  • Ondokuz Mayis University Faculty of Medicine
    Samsun, 55150, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly as participant consent did not include public data sharing.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Jul 2026, 2 months.

Of 41 observational studies under Erectile Dysfunction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 77. This study's 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 16, 2026
StartActual
May 7, 2026
Primary completionActual
Jul 30, 2026
CompletionActual
Jul 30, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938502
Responsible party
Murat Gulsen (Assistant Professor, Ondokuz Mayıs University) — Principal investigator
First posted
Nov 16, 2026
Start date
May 7, 2026
Primary completion
Jul 30, 2026
Completion
Jul 30, 2026
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion